NordiQC give Optibodies™ high scores once again

news April 23 2021

We are proud to announce that our best performing Optibodies™ MSH6 have achived optimal result in the latest run 61 in the independent quality assesment by NordicQC. Our other top performing optibodies™ Desmin achivee significant results in latest reports. Read below to learn more about our Optibodies™.



The aim of Nordic immunohistochemical Quality Control (NordiQC) is to promote the quality of immunohistochemistry and expand its clinical use by arranging schemes for immunohistochemical proficiency testing and providing examples of recommended protocols, tissue controls and other relevant information including descriptions of epitopes and technical protocol parameters.

Our best performing Optibodies™


Desmin is an intermediate filament expressed in smooth and skeletal muscle cells and used as a marker to distinguish tumors of myogenic origin. Our desmin antibody (clone BS21) has great analytical and technical sensitivity.

View product here.


MSH6 (MutS Homolog 6) is a member of DNA mismatch repair system and it is associated with certain colon cancer, colorectal cancer, and endometrial cancer. Loss of MSH6 expression can be visualized in these cancer types by our MSH6 antibody (clone BSR100).

View product here.


About Optibodies™

Optibodies™ is a series of premium monoclonal antibodies, optimized and extensively validated for IHC using recommended control tissues and staining criteria. They represent clones that has not been on the market previously and are created to provide excellent alternatives to more challenging clones.

Key features include:
– High analytical specificity and sensitivity
– Optimized for high pH hier
– Excellent Stability
– Concentrated Antibodies
– Optimal staining results in external quality assessments

View all our Optibodies™ products here.

Contact us for more information here!

Contact Us

Subscribe to our newsletter

Get the latest news within your area of research to your inbox.
Subscribe →